AAAAAA
Results:
1-19
|
Results: 19
Authors:
Richards, T
Crown, J
Citation: T. Richards et J. Crown, Diplomatic champion of wide public health issues, BR MED J, 322(7294), 2001, pp. 1086-1086
Authors:
Cardoso, F
Ferreira, AF
Crown, J
Dolci, S
Paesmans, M
Riva, A
Di Leo, A
Piccart, MJ
Citation: F. Cardoso et al., Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicinin the adjuvant treatment of node positive breast cancer: Results of a feasibility study, ANTICANC R, 21(1B), 2001, pp. 789-795
Authors:
Crown, J
Citation: J. Crown, A "bureausceptic" view of cancer drug rationing, LANCET, 358(9294), 2001, pp. 1660-1660
Authors:
Huober, J
Crown, J
Citation: J. Huober et J. Crown, New aspects in adjuvant therapy for breast cancer - Interview with John Crown, GEBURTSH FR, 61(8), 2001, pp. 637-638
Authors:
Di Leo, A
Crown, J
Nogaret, JM
Duffy, K
Bartholomeus, S
Dolci, S
Rowan, S
O'Higgins, N
Paesmans, M
Larsimont, D
Riva, A
Piccart, MJ
Citation: A. Di Leo et al., A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer, ANN ONCOL, 11(2), 2000, pp. 169-175
Authors:
Crown, J
Citation: J. Crown, Docetaxel: Efficacy in first- and second-line therapy of advanced breast cancer, ONKOLOGIE, 23, 2000, pp. 1-3
Authors:
Crown, J
O'Leary, M
Citation: J. Crown et M. O'Leary, Taxanes as adjuvant for breast cancer - Reply, LANCET, 356(9228), 2000, pp. 508-508
Authors:
Crown, J
Citation: J. Crown, Breast-cancer treatment put into question, LANCET, 355(9217), 2000, pp. 1828-1829
Authors:
Crown, J
O'Leary, M
Citation: J. Crown et M. O'Leary, The taxanes: an update, LANCET, 355(9210), 2000, pp. 1176-1178
Authors:
Crown, J
Coiffier, B
Cortes-Funes, H
Guillaume, T
Kanz, L
Kvalheim, G
Marty, M
Symann, M
Citation: J. Crown et al., ESTIC position paper: High-dose chemotherapy for breast cancer, investigation should continue, ANN ONCOL, 10(8), 1999, pp. 903-905
Authors:
Breathnach, O
Donnellan, P
Collins, D
McNicholas, W
Crown, J
Citation: O. Breathnach et al., Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy:Case report and review of the literature, ANN ONCOL, 10(4), 1999, pp. 461-465
Authors:
Chan, S
Friedrichs, K
Noel, D
Pinter, T
Van Belle, S
Vorobiof, D
Duarte, R
Gil, MG
Bodrogi, I
Murray, E
Yelle, L
von Minckwitz, G
Korec, S
Simmonds, P
Buzzi, F
Mancha, RG
Richardson, G
Walpole, E
Ronzoni, M
Murawsky, M
Alakl, M
Riva, A
Crown, J
Citation: S. Chan et al., Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer, J CL ONCOL, 17(8), 1999, pp. 2341-2354
Authors:
Hudis, C
Fornier, M
Riccio, L
Lebwohl, D
Crown, J
Gilewski, T
Surbone, A
Currie, V
Seidman, A
Reichman, B
Moynahan, M
Raptis, G
Sklarin, N
Theodoulou, M
Weiselberg, L
Salvaggio, R
Panageas, KS
Yao, TJ
Norton, L
Citation: C. Hudis et al., 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study, J CL ONCOL, 17(4), 1999, pp. 1118-1126
Authors:
Crown, J
Citation: J. Crown, Taxoid therapy of breast cancer, ONKOLOGIE, 22, 1999, pp. 29-30
Authors:
Crown, J
Citation: J. Crown, Phase III randomized trials of docetaxel in patients with metastatic breast cancer, SEMIN ONCOL, 26(3), 1999, pp. 33-38
Authors:
Crown, J
Citation: J. Crown, A review of the efficacy and safety of docetaxel as monotherapy in metastatic breast cancer, SEMIN ONCOL, 26(1), 1999, pp. 5-9
Authors:
Crown, J
Citation: J. Crown, Extending prescribing: issues and opportunities, J ROY COL P, 33(6), 1999, pp. 503-505
Authors:
Nabholtz, JM
Crown, J
Citation: Jm. Nabholtz et J. Crown, Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: Preliminary results, SEMIN ONCOL, 25(6), 1998, pp. 4-9
Authors:
Crown, J
Citation: J. Crown, Evolution in the treatment of advanced breast cancer, SEMIN ONCOL, 25(5), 1998, pp. 12-17
Risultati:
1-19
|